The price you pay for Gilenya may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the ...

The cost of Gilenya can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Gilenya. As with all ...

Gilenya was first approved in 2010 and has been a big brand for Novartis, although it is facing strong competition from newer drugs such as Roche's Ocrevus (ocrelizumab), Merck KGaA's Mavenclad ...

Gilenya made revenues of $2.8 billion in 20021, with half of that total coming from the US market, although it has started to shrink as a result of increased competition in the market for ...

The Swiss pharmaceutical company Novartis will probably have to face up to the allegations of a whistleblower regarding the sale of the multiple sclerosis drug Gilenya. According to Reuters ...

A US court has ordered generic drug makers to stop selling a copy of Gilenya in US. The annual sales of Gilenya, a drug used to treat multiple sclerosis, was about $3.3 billion in 2018.